Back to 
ExodusPoint Capital Management, LP
ExodusPoint Capital Management, LP
AMLX
Showing 3 of 11 quarters
Position history for ExodusPoint Capital Management, LP's holdings in Amylyx Pharmaceuticals, Inc.
No. ExodusPoint Capital Management exited its AMLX (Amylyx Pharmaceuticals) position in Q2 2025. Its Q1 2025 13F listed 59,491 shares worth $211,000. ExodusPoint Capital Management first reported AMLX in Q2 2022 and held it in 9 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$402,000
Total Shares Change
-106,237
Quarter-by-Quarter History
Other major holders of AMLX: FMR LLC, Viking Global Investors LP